Cargando…
VCAM-1 Density and Tumor Perfusion Predict T-cell Infiltration and Treatment Response in Preclinical Models()()
Cancer immunotherapies have demonstrated durable responses in a range of different cancers. However, only a subset of patients responds to these therapies. We set out to test if non-invasive imaging of tumor perfusion and vascular inflammation may be able to explain differences in T-cell infiltratio...
Autores principales: | Riegler, Johannes, Gill, Herman, Ogasawara, Annie, Hedehus, Maj, Javinal, Vincent, Oeh, Jason, Ferl, Gregory Z., Marik, Jan, Williams, Simon, Sampath, Deepak, Schartner, Jill, Carano, Richard A.D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744528/ https://www.ncbi.nlm.nih.gov/pubmed/31521051 http://dx.doi.org/10.1016/j.neo.2019.08.003 |
Ejemplares similares
-
Monitoring and Targeting Anti-VEGF Induced Hypoxia within the Viable Tumor by (19)F–MRI and Multispectral Analysis
por: Shi, Yunzhou, et al.
Publicado: (2017) -
Blocking VCAM-1 ameliorates hypertensive cardiac remodeling by impeding macrophage infiltration
por: Qiu, Ze-Yang, et al.
Publicado: (2022) -
VCAM1 expression in the myocardium is associated with the risk of heart failure and immune cell infiltration in myocardium
por: Wang, Tongyu, et al.
Publicado: (2021) -
IAP inhibitor, Embelin increases VCAM-1 levels on the endothelium, producing lymphocytic infiltration and antitumor immunity
por: Nakajima, Kosei, et al.
Publicado: (2020) -
VCAM-1 Is Upregulated in Uranium Miners Compared to Other Miners
por: Ass’ad, Nour A., et al.
Publicado: (2021)